Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen, speaks on nontherapeutic approaches to manage symptom burden of psoriatic arthritis.
Diet, meditation, and exercise are several nontherapeutic strategies to manage symptom burden of psoriatic arthritis, said Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen.
Transcript
What are some nondrug treatment approaches that can help manage symptom burden of psoriatic arthritis?
Now, as far as the nondrug treatment approach, in terms of helping manage symptom burden, I think that's very important to consider in a disease like psoriatic arthritis, because of the elements that we've talked about. Apart from inflammation, and the sequelae of that inflammation, like pain, like fatigue, there are nondrug approaches that we can take.
That includes having a healthy diet, trying low-impact exercise, taking care of one's mental health. And we've talked about fatigue as an example of psoriatic arthritis causing that.
So, Tai Chi, meditation, telteherapy—these are all strategies that help ease fatigue over time. At the same time, patients can find some benefit in being able to join support programs, share their psoriatic arthritis experiences with other patients and families. And, of course, make sure that this management plan and the approach that's taken both from a therapeutic, but also nontherapeutic approach is individualized and personalized, because again, there's no one-size-fits-all approach here.
Each person living with psoriatic arthritis is very unique. We'll need to test out, again, different management strategies with their health care provider in that shared decision-making context to see what works best for them.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More